Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Dexmedetomidine

×

Overview

What is Dexmedetomidine?

Dexmedetomidine hydrochloride injection is a sterile, nonpyrogenic solution suitable for intravenous infusion following dilution. Dexmedetomidine hydrochloride is the S-enantiomer of medetomidine and is chemically described as (+)-4-(S)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole monohydrochloride. Dexmedetomidine hydrochloride has a molecular weight of 236.7 and the empirical formula is CHN• HCl and the structural formula is:

Dexmedetomidine hydrochloride is a white or almost white powder that is freely soluble in water and has a pKa of 7.1. Its partition coefficient in-octanol: water at pH 7.4 is 2.89. Dexmedetomidine hydrochloride injection is supplied as a clear, colorless, isotonic solution with a pH of 4.5 to 7.0. Each mL contains 118 mcg of dexmedetomidine hydrochloride equivalent to 100 mcg (0.1 mg) of dexmedetomidine and 9 mg of sodium chloride in water and is to be used after dilution. The solution is preservative-free and contains no additives or chemical stabilizers.



What does Dexmedetomidine look like?



What are the available doses of Dexmedetomidine?

Dexmedetomidine Hydrochloride Injection, 200 mcg/2 mL (100 mcg/mL) in a glass vial. To be used after dilution. ()

What should I talk to my health care provider before I take Dexmedetomidine?

How should I use Dexmedetomidine?

Dexmedetomidine hydrochloride injection is a relatively selective alpha -adrenergic agonist indicated for:

Individualize and titrate dexmedetomidine hydrochloride injection dosing to desired clinical effect. ()

Administer dexmedetomidine hydrochloride injection using a controlled infusion device. ()

Dilute the 200 mcg/2 mL (100 mcg/mL) vial contents in 0.9% sodium chloride solution to achieve required concentration (4 mcg/mL) prior to administration. ()


What interacts with Dexmedetomidine?

Sorry No Records found


What are the warnings of Dexmedetomidine?

Sorry No Records found


What are the precautions of Dexmedetomidine?

Sorry No Records found


What are the side effects of Dexmedetomidine?

Sorry No records found


What should I look out for while using Dexmedetomidine?

None


What might happen if I take too much Dexmedetomidine?

The tolerability of dexmedetomidine hydrochloride injection was studied in one study in which healthy adult subjects were administered doses at and above the recommended dose of 0.2 to 0.7 mcg/kg/hr. The maximum blood concentration achieved in this study was approximately 13 times the upper boundary of the therapeutic range. The most notable effects observed in two subjects who achieved the highest doses were first degree atrioventricular block and second degree heart block. No hemodynamic compromise was noted with the atrioventricular block and the heart block resolved spontaneously within one minute.

One patient who received a loading bolus dose of undiluted dexmedetomidine hydrochloride injection (19.4 mcg/kg), had cardiac arrest from which he was successfully resuscitated.


How should I store and handle Dexmedetomidine?

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Do not refrigerate.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Do not refrigerate.Dexmedetomidine Hydrochloride Injection, 200 mcg/2 mL (100 mcg/mL), is a sterile, nonpyrogenic, clear, colorless solution. It is available in a 2 mL clear glass vial. Vials are intended for single use only. NDC 17478-055-02         2 mL single-dose vial in box of 10 Dexmedetomidine Hydrochloride Injection, 200 mcg/2 mL (100 mcg/mL), is a sterile, nonpyrogenic, clear, colorless solution. It is available in a 2 mL clear glass vial. Vials are intended for single use only. NDC 17478-055-02         2 mL single-dose vial in box of 10


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Dexmedetomidine hydrochloride injection is a relatively selective alpha-adrenergic agonist with sedative properties. Alpha selectivity is observed in animals following slow intravenous infusion of low and medium doses (10 to 300 mcg/kg). Both alpha and alpha activity is observed following slow intravenous infusion of high doses (≥ 1000 mcg/kg) or with rapid intravenous administration.

Non-Clinical Toxicology
None

Although the pressor activity of desmopressin acetate is very low compared with the antidiuretic activity, use of doses as large as 0.3 mcg/kg of desmopressin acetate with other pressor agents should be done only with careful patient monitoring. The concomitant administration of drugs that may increase the risk of water intoxication with hyponatremia, (e.g., tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, NSAIDs, lamotrigine and carbamazepine) should be performed with caution.

Desmopressin acetate has been used with epsilon aminocaproic acid without adverse effects.

Dexmedetomidine hydrochloride injection should be administered only by persons skilled in the management of patients in the operating room setting. Due to the known pharmacological effects of dexmedetomidine hydrochloride injection, patients should be continuously monitored while receiving dexmedetomidine hydrochloride injection.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).